The differences in homeostasis model assessment values in type 2 diabetic patients with different lengths of history of diabetes
ABSTRACT Objective Type 2 diabetes (T2DM) is characterized by the progressive deterioration of pancreatic islet β-cell function over time and insulin resistance. Knowing more about the differences in pancreatic islet function in T2DM patients who have had diabetes for different lengths of time can...
Main Authors: | Chen Wang, Zaibo Liu, Peng Zhang, Xiaolong Ma, Kui Che, Yangang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Brazilian Society of Endocrinology and Metabolism
2019-05-01
|
Series: | Archives of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019005003103&lng=en&tlng=en |
Similar Items
-
Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells
by: Ewa Gurgul-Convey
Published: (2020-08-01) -
Challenges in Diagnosing Type 1 Diabetes in Different Populations
by: Marian Rewers
Published: (2012-04-01) -
Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients
by: Meng-jie Tang, et al.
Published: (2019-09-01) -
Mesenchymal Stem Cells: A Trump Card for the Treatment of Diabetes?
by: Elisabetta Donzelli, et al.
Published: (2020-05-01) -
Adapting Protocols or Models for Use in Insulin-Requiring Diabetes and Islet Transplant Recipients
by: Glenn M. Ward, et al.
Published: (2021-07-01)